School of Psychology, University of Lincoln, Lincoln, UK.
Department of Clinical Psychology and Neuropsychology, Nottingham University Hospitals, Nottingham, UK.
Eur J Oncol Nurs. 2023 Aug;65:102359. doi: 10.1016/j.ejon.2023.102359. Epub 2023 Jun 7.
Haematopoietic stem cell transplantation (HSCT) is an intensive procedure associated with elevated psychological distress, particularly during the initial stages. Based on self-regulatory theory, a prophylactic group intervention was developed to mitigate this distress by targeting perceptions of HSCT and coping. This study evaluated the feasibility of delivering the intervention and of conducting a randomised clinical trial to assess efficacy.
Adults from consecutive referrals at two transplant centres were randomised to the intervention or to treatment as usual at each site. Psychological distress (primary outcome), HSCT perceptions, and coping were assessed at baseline, on transplant day, and two and four weeks after transplantation.
Of 99 eligible patients, 45 consented. Main barriers to consent were insufficient time prior to transplantation, competing priorities, being unwell, and travel distance. Of 21 participants randomised to the intervention, five attended. Main barriers to attendance included insufficient time prior to transplantation and having competing priorities. Groups could not be held sufficiently frequently to enable attendance prior to transplantation, as randomising participants to the control group limited accrual. Anxiety peaked two weeks following transplantation. Depression increased throughout the acute phase. Clinical levels of distress were observed in 42% of patients during HSCT. Intervention effects were small but sample sizes for a full trial appeared feasible.
Multimodal prehabilitation is required but there are specific barriers to delivering a group-based intervention and conducting a trial. Group prehabilitation requires customisation and better integration with routine care, such as patient screening, personalisation, and options for remote delivery.
造血干细胞移植(HSCT)是一种强化治疗程序,与较高的心理困扰有关,特别是在初始阶段。基于自我调节理论,开发了一种预防性的小组干预措施,通过针对 HSCT 和应对的认知来减轻这种困扰。本研究评估了提供干预措施和进行随机临床试验以评估疗效的可行性。
连续转诊到两个移植中心的成年人在每个中心随机分配到干预组或常规治疗组。在基线、移植日以及移植后两周和四周评估心理困扰(主要结局)、HSCT 认知和应对。
在 99 名符合条件的患者中,有 45 名同意参加。同意的主要障碍是移植前时间不足、优先事项竞争、身体不适和距离远。在随机分配到干预组的 21 名参与者中,有 5 名参加。参加的主要障碍包括移植前时间不足和优先事项竞争。由于将参与者随机分配到对照组会限制入组,因此无法在移植前安排足够频繁的小组会议以允许参加。焦虑在移植后两周达到峰值。抑郁在急性期内逐渐增加。在 HSCT 期间,42%的患者出现临床水平的困扰。干预效果较小,但全试验的样本量似乎可行。
需要进行多模式康复前治疗,但提供小组干预和进行试验存在特定的障碍。小组康复前治疗需要定制化,并更好地与常规护理整合,如患者筛查、个性化和远程提供选项。